Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Lyophilized viper antivenin and preparation method thereof

An anti-venom and viper venom technology, applied in the field of anti-venom and preparation technology, can solve the problems of strong toxicity, large difference in antigen specificity, large amount of detoxification, etc., achieve high titer, reduce the incidence of adverse reactions, guarantee therapeutic effect

Active Publication Date: 2010-09-01
浙江健博生物科技股份有限公司
View PDF2 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, Viper rotundus is a subspecies of Viperidae snakes, and the antigen specificity of different subspecies is quite different. F(ab′) produced by a single snake venom immune plasma 2 It can only be specifically combined with the corresponding antigenic determinant. In addition, Viper has a large amount of detoxification at one time and strong toxicity, so its limitation is obvious; while the concentrated stock solution uses chloroform as a solvent and has a large content (1.4-0.6%) and alum flocculation precipitation Proteins have potential damage to the human body; on the other hand, not only the finished product obtained by serum hydrolysis and salting out has low purity (F(ab′) 2 ≥60%) lead to low antibody titers, and because the antiserum contains more large molecular weight IgG and Fc fragments that activate complement, it becomes the most important factor in clinical antiserum allergic reactions except individual differences. Therefore, if you want to be more thorough It is far from enough to remove these allergenic ingredients only by salting out in the preparation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lyophilized viper antivenin and preparation method thereof
  • Lyophilized viper antivenin and preparation method thereof
  • Lyophilized viper antivenin and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0023] Two to three lyophilized products of viper subspecies were purchased from different places in southern China.

[0024] Mix the lyophilized poisonous products of different viper subspecies from the above origins, and detect LD 50 As an immunogen; the horse used for immunization is a Kunming pony that has passed the quarantine inspection according to the relevant provisions of the three relevant provisions of the "Chinese Pharmacopoeia" in 2010; the mouse used in the experiment is a Kunming white mouse, SPF grade, weighing 18-20g; pepsin has been tested for class A substances Qualified, specific activity 1:3000.

[0025] (1) Immunization of horses and collection of immune plasma

[0026] Before immunization, the horses were immunized twice with concentrated tetanus toxoid, and after the viper venom was gradually detoxified with formaldehyde, an adjuvant was added (the concentration of the venom was 0.2 mg / ml). Immunization is divided into basic immunity and hyperimmunit...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a lyophilized viper antivenin and a preparation method thereof, belonging to biochemical products, more particularly relating to an antivenin and a preparation technology thereof. The mass ratio of the antivenin and viper venom is 15:1, which can specifically neutralize the viper venom injected to mouse; as determined by immunodiffusion, the immunoprecipitation line appears in case that the ratio of viper antivenin F(ab')2 in lyophilized form to viper venom is 8:1; and other detected items conform to the quality standard of antivenin in Chinese Pharmacopoeia 2010. The detection of Phenyl-Sepharose (low-sub) FF column chromatography result shows that: activity is centralized at eluting peak 1, micromolecule impurity proteins are centralized at penetration peal, eluting peak 2 and eluting peak 3. According to the technology of the invention, immune blood plasma is resulted from viper venom immune horse, IgG is prepared by salting out the immune blood plasma, and F(ab')2 active fragment is obtained after the IgG is subject to enzymolysis and purification by a hydrophobic column. The lyophilized viper antivenin has strong specificity, high potency and more than 85% of the purity of antivenin F(ab')2 in lyophilized form.

Description

technical field [0001] The invention belongs to biomedical products, in particular to antivenom and its preparation process. Background technique [0002] Vipers (Vipera russelli siamensi) belong to the family Viperidae, and are highly venomous snakes that mainly contain blood circulation toxins. Vipers in my country are mainly distributed in Guangxi, Guangdong, Fujian and Taiwan. Vipers are active day and night, curled up into groups, move slowly, and have a ferocious snake nature. Viper venom mainly contains blood circulation poison, and the toxic components are mainly coagulation toxins, as well as hemolytic toxins, fibrinolytic toxins, anticoagulant components, platelet accumulation and denaturation components, and hemorrhagic toxins. After a person is bitten, the onset is acute, the symptoms are severe, the wound is swollen and painful, bleeding, causing extensive coagulation in the blood vessel, DIC dangerous symptoms, the patient may cause anemia and jaundice, renal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/395A61K35/16A61P39/02A61P37/08
Inventor 范泉水郑颖邱薇张富强叶锋平周卫国张志晓
Owner 浙江健博生物科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products